Click here for links to all Expanded Tables of Contents EXPANDED TABLE OF CONTENTS VOLUME 9, NUMBER 10    OCTOBER 2006 TREATMENT HIGHLIGHTS SCHIZOPHRENIA AND VIOLENT BEHAVIOR In patients with recurrent episodes of schizophrenia, risk for violence is found to be influenced by clinical and nonclinical factors. POSTTRAUMATIC STRESS DISORDER AND DEPRESSION IN BATTLE-INJURED SOLDIERS Among seriously injured soldiers, severity of physical problems shortly after the injury is found to be associated with the persistence and later onset of posttraumatic stress disorder (PTSD) and depression. IMPACT OF DEPRESSION ON JOB PERFORMANCE In patients with depression, several aspects of job performance are found to be negatively affected. QUICKSTATS Drug-Related Emergency Department Visits PSYCHOPHARMACOLOGY NOTE KETAMINE INJECTION IN THE TREATMENT OF DEPRESSION Rapid antidepressant effects are found to result from intravenous injection of ketamine. FDA NEWS AND REVIEW Product Safety Information: The Warnings Section in the labeling of Paxil and Paxil CR (paroxetine hydrochloride) has been revised to include warnings of increased risk of suicide in adults, particularly in young adults. Product Safety Information: An FDA Public Health Advisory warns that combined use of triptans (5-hydroxytryptamine receptor agonists used to treat migraine headaches) and SSRIs or SNRIs may result in life-threatening serotonin syndrome. Approval Aricept Indication is Expanded to Include Treatment of Severe Alzheimer’s Disease Approval Risperdal Receives New Indication: Treatment of Irritability Associated With Autistic Disorder in Children and Adolescents ASSESSMENT Trauma Screening Questionnaire (TSQ) [There is open access to the TSQ; user name is not required.] RESOURCES Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials.